Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.
about
Aptamers: A promising chemical antibody for cancer therapyA Divalent Ion Is Crucial in the Structure and Dominant-Negative Function of ID Proteins, a Class of Helix-Loop-Helix Transcription RegulatorsSmall-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis.Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms.The Id-protein family in developmental and cancer-associated pathways.Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.Ku regulates signaling to DNA damage response pathways through the Ku70 von Willebrand A domain.Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.Structural insights into interacting mechanism of ID1 protein with an antagonist ID1/3-PA7 and agonist ETS-1 in treatment of ovarian cancer: molecular docking and dynamics studies.ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes.
P2860
Q26766832-B1BD3D6D-10B4-44A4-9BEA-A8EEE6DB0750Q27674951-496BB65A-0018-4DF9-A7FE-77A03179E1E3Q33873915-1F45885F-94CD-4FCB-A8C6-BCAFCBC126C5Q34698624-05B98536-17A1-404F-B0F6-C0A2564F8B50Q35618867-AEC69517-82C8-445F-A960-AA10CEA98477Q37112937-A1F2F1FA-12B1-43DB-9834-B5BFD1768475Q38032893-9FCF6772-34B7-4042-B087-B7107603C2EFQ38857627-0C39D662-8037-4407-AEC1-3AB5F0C3E4F2Q38898841-770E87E9-57C9-4D82-9510-6160B72E414FQ38924713-01D46CC2-F570-4813-8C59-33C1A63F0815Q39103288-5AAE34FC-5FB3-4F4D-A293-06486AB99DC8Q39164711-3A6BC12E-B8FF-487A-A810-6E31A103EEBAQ39450922-20FBB178-C50C-4EF9-871B-9361433B8DC2Q39558334-73DA6B7C-DB21-4E97-B376-E6F0800BB0F3Q54503142-6CE9BCE7-48F2-43BD-933A-5E1C03657D3CQ54508849-D023CBB4-557D-4CC6-AC68-0B7BA46342D4
P2860
Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@ast
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@en
type
label
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@ast
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@en
prefLabel
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@ast
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@en
P2093
P2860
P356
P1476
Inhibition of Id proteins by a ...... tosis in ovarian cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605897
P407
P577
2010-09-14T00:00:00Z
P5875
P6179
1047737880